ZHOU Qun, DUAN Wen-hu, Dana J.Cohen, Jean M.Bidlack, Mark P.Wentl,, . ZHOU Qun,et al:Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methy] benzomorphanSynthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methyl] benzomorphanJ. Acta Pharmaceutica Sinica, 2003, 38(10): 748-753.
Citation: ZHOU Qun, DUAN Wen-hu, Dana J.Cohen, Jean M.Bidlack, Mark P.Wentl,, . ZHOU Qun,et al:Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methy] benzomorphanSynthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methyl] benzomorphanJ. Acta Pharmaceutica Sinica, 2003, 38(10): 748-753.

ZHOU Qun,et al:Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methy] benzomorphanSynthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methyl] benzomorphan

  • AimTo design and synthesize new chiral 8-(substituted)amino-analogues of 3-[(tetrahydro-2-furanyl)methyl] benzomorphans, to expand knowledge of the structure-activity relationship(SAR) for 8-aminobenzomorphan.MethodsTarget compounds were synthesized from the 8- triflate of the optically active 3-[(tetrahydro-2-furanyl)methyl]-2,6-methano- benzomorphans using Pd-catalyzed aminations.Opioid receptor binding experiments were performed to evaluate their biological activities.ResultsBoth 8-amino and 8-phenylamino analogues showed lower binding affinity for μ, δ and κ receptors than corresponding 8-hydroxy-3-[(tetrahydro-2-furanyl)methyl]-2,6-methano-benzomorphan in vitro. ConclusionThe relative poor binding affinity of the target compounds did not warrant conducting the in vivo studies to determine if they have the profile(κ agonist/μ antagonist) that will be potentially useful in the treatment of drug addiction.Further study is in progress.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return